SCHEMBL7318626

SCHEMBL7318626

N#Cc1cn2cc(Br)nc(Br)c2n1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455637 0.78
SCHEMBL7318610 0.73 CTSK (0.43)
SCHEMBL5552998 0.71 ADORA1 (0.34) ADORA1
SCHEMBL19629696 0.71 ADORA1 (0.34) ADORA1
SCHEMBL24738154 0.66 CYP11B1 (0.31)
SCHEMBL7328467 0.64 ADORA1 (0.71) ADORA1
SCHEMBL30929199 0.64 GRM5 (0.35) ADORA1
SCHEMBL9970947 0.63
SCHEMBL14786077 0.63 PIK3CG (0.55)
SCHEMBL103894 0.63 HTR2C (0.53) ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120141305-A Detection method of heat dissipation plate 苏州常济毓自动化设备有限公司 2025-06-13 CN claimed
WO-2025034782-A1 CHARGE-ALTERING RELEASABLE TRANSPORTERS FROM AMINO ALCOHOL INITIATORS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-02-13 WO claimed
CN-118561275-B Preparation method and application of atomic-level Lewis acid-base modified functional carbon material XINTE ENERGY CO.,LTD. (CN) 2026-05-26 CN disclosed
WO-2026104567-A1 A METHOD FOR THE QUANTIFICATION OF CHLORINATED PARAFFINS THERMO FISHER SCIENTIFIC (BREMEN) GMBH (DE) 2026-05-21 WO disclosed
US-12623992-B2 Key intermediate for synthesis of prostaglandin compound and preparation method thereof SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) 2026-05-12 US disclosed
US-12602206-B2 Systems and methods for code generation SAP SE (DE) 2026-04-14 US disclosed
US-20260097111-A1 ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS CORNER THERAPEUTICS, INC. (US) 2026-04-09 US disclosed
EP-3902231-B1 SYSTEMS AND METHODS FOR SECURE ACCESS SMART HUB FOR CYBER-PHYSICAL SYSTEMS HONEYWELL INT INC (US) 2026-04-01 EP disclosed
US-12580673-B2 Optical communication system transmitting and receiving optical subcarriers having different spectral widths and/or power values INFINERA CORPORATION (US) 2026-03-17 US disclosed
US-12580657-B2 Out-of-band communication channel for subcarrier-based optical communication systems INFINERA CORPORATION (US) 2026-03-17 US disclosed
US-12552978-B2 Method of reacting CO2 by emulsifying concrete and use in oilwell cementing SAUDI ARABIAN OIL COMPANY (SA) 2026-02-17 US disclosed
CN-110342190-B Return guide device and guide device 意大利雷吉那链条集团 2022-04-05 CN disclosed
US-11296812-B2 Out-of-band communication channel for subcarrier-based optical communication systems INFINERA CORPORATION (US) 2022-04-05 US disclosed
EP-3970292-A1 OUT-OF-BAND COMMUNICATION CHANNEL FOR SUB-CARRIER-BASED OPTICAL COMMUNICATION SYSTEMS Infinera Corporation (US) 2022-03-23 EP disclosed
US-11274230-B1 Polishing composition and method of polishing a substrate having enhanced defect inhibition ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. (US) 2022-03-15 US disclosed
CN-216055590-U Signal transfer box of control system for submersible vehicle 中国舰船研究设计中心 2022-03-15 CN disclosed
US-11239935-B2 Out-of-band communication channel for subcarrier-based optical communication systems INFINERA CORPORATION (US) 2022-02-01 US disclosed
US-5028605-A Antispasmodic, bronchodilators, uterine relaxants, cardiac analeptics, neurosedatives L'UNIVERSITE DE MONTPELLIER I (FR) 1991-07-02 US disclosed
EP-0348392-A1 8-ALKYLAMINOIMIDAZO[1,2-A]PYRAZINES AND DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY Université Montpellier I (FR) 1990-01-03 EP disclosed
WO-1988004298-A1 8-ALKYLAMINOIMIDAZO[1,2-A]PYRAZINES AND DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1988-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552978-B2 Method of reacting CO2 by emulsifying concrete and use in oilwell cementing CCNE2, WNT3A, AQP3 ADORA1 2887/4885
US-12602206-B2 Systems and methods for code generation EIF2S1, EIF2S2, SET ADORA1 4023/4885
US-12580673-B2 Optical communication system transmitting and receiving optical subcarriers having different spectral widths and/or power values STAT4, TANK, IKBKG ADORA1 3331/4885
US-20260097111-A1 ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS TLR7, INPP5D, PLCD1 ADORA1 986/4885
US-12623992-B2 Key intermediate for synthesis of prostaglandin compound and preparation method thereof PTGS1, PTGIS, PGF ADORA1 2642/4885
US-12580657-B2 Out-of-band communication channel for subcarrier-based optical communication systems GJB2, GJA1, CRY2 ADORA1 2946/4885
US-11274230-B1 Polishing composition and method of polishing a substrate having enhanced defect inhibition POF1B, PPP5C, POLB ADORA1 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.